{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:05:53Z","timestamp":1789891553910,"version":"4.0.1"},"reference-count":31,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2018,8,3]]},"DOI":"10.1080\/13543776.2018.1502748","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T13:30:57Z","timestamp":1532611857000},"page":"635-646","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":22,"title":["New strategies for patenting biological medicines used in rheumatoid arthritis treatment"],"prefix":"10.1080","volume":"28","author":[{"given":"Rodrigo Ayres de","family":"Oliveira","sequence":"first","affiliation":[{"name":"Academy of Intellectual Property and Innovation, National Institute of Industrial Property (INPI-Brazil), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda M.","family":"Fierro","sequence":"additional","affiliation":[{"name":"Academy of Intellectual Property and Innovation, National Institute of Industrial Property (INPI-Brazil), Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2016-0027"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1362-7"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1209508"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.05.010"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.11606\/issn.2176-7262.v43i3p283-291"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.10.003"},{"issue":"3","key":"CIT0009","first-page":"357","volume":"34","author":"Calabr\u00f2 A","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"CIT0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.18553\/jmcp.2011.17.s9-b.S14","volume":"17","author":"Agarwal SK","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2012.721769"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/art.39480"},{"issue":"1","key":"CIT0013","first-page":"355","volume":"9","author":"Myrick ER","year":"1993","journal-title":"Santa Clara High Tech L J"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.12659\/PJR.883763"},{"issue":"2","key":"CIT0019","first-page":"144","volume":"9","author":"Gavril\u0103 BI","year":"2016","journal-title":"J Med Life"},{"key":"CIT0020","volume-title":"Methods of prognosing and administering treatment for inflammatory disorders","author":"Mirich J. Genqual Corp and Mirich Jonatan, assignee","year":"2012"},{"key":"CIT0021","volume-title":"Methods for treating, diagnosing, and monitoring rheumatoid arthritis","author":"Glyn JRD","year":"2012"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009639"},{"key":"CIT0023","volume-title":"Full human anti-TNF-alpha monoclonal antibody, preparation method and use thereof","author":"Guo H","year":"2011"},{"key":"CIT0024","volume-title":"Compositions and methods for treating rheumatoid arthritis","author":"Padley RJ","year":"2015"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.168"},{"key":"CIT0026","volume-title":"inventors","author":"Martin JH","year":"2011"},{"key":"CIT0027","volume-title":"Anti-CD20 therapeutic compositions and methods","author":"Damle NK","year":"2008"},{"key":"CIT0028","volume-title":"Compositions comprising TNF-alpha and IL-6 antagonists and methods of use thereof","author":"Misher LE","year":"2011"},{"key":"CIT0029","volume-title":"Crystallization of anti-CD20 antibodies","author":"Wilkins JA","year":"2009"},{"issue":"6","key":"CIT0031","first-page":"578","volume":"67","author":"Brodniewicz T","year":"2010","journal-title":"Acta Pol Pharm"},{"key":"CIT0032","volume-title":"Compositions and methods for treating rheumatoid arthritis","author":"Cuff C","year":"2015"},{"key":"CIT0034","volume-title":"Formulations of single domain antigen binding molecules","author":"Fernandez JE","year":"2016"},{"key":"CIT0035","volume-title":"Method for preparing active form of TNFR-Fc fusion protein","author":"Won HS","year":"2013"},{"key":"CIT0037","unstructured":"Behrens TW, Owczarczyk K, Townsend MJ, inventors. Genentech Inc, Hoffmann La Roche, assignees. Biological markers and methods for predicting response to B-cell antagonists. Sep; 2012. p. 07. WO2012118750."},{"key":"CIT0038","unstructured":"Genentech, About us. Genentech, Inc. 2018. [cited 2017 Oct 3]. Available from: https:\/\/www.gene.com\/about-us"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-006-9167-5"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-2-3"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2018.1502748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T06:27:21Z","timestamp":1661668041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2018.1502748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,31]]},"published-print":{"date-parts":[[2018,8,3]]}},"alternative-id":["10.1080\/13543776.2018.1502748"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2018.1502748","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}